As of Feb 05
| +0.18 / +1.87%|
The 3 analysts offering 12-month price forecasts for Enzymotec Ltd have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +12.13% increase from the last price of 9.81.
The current consensus among 4 polled investment analysts is to Buy stock in Enzymotec Ltd. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.